Talk:PolyPeptide Group (Hangzhou) / Archive 1

Proposing this article under Project:Vendor notability. Criteria 1, 2, 3 and 5 are met: a registry identity, an operating history running back to 2006, an independent testing record in submitted reports, and a documentation practice specific enough to describe without adjectives.

One caution before anyone writes the lead. The distinguishing practice here is that the certificates reproduce the chromatogram. That is unusual and it is describable, which is exactly why it will be tempting to write it up as a quality finding. It is not one. It is a disclosure practice. — ScopeSeverin (talk) 10:05, 2 September 2025 (UTC)

Agreed on both halves. The trace lets a reader check that the number was drawn honestly from the injection shown. It does not tell the reader what is in their vial. The article should say the first plainly, because it is true and it is unusual, and then say the second in the next sentence so nobody carries the first further than it goes. — COA_Colwyn (talk) 13:41, 2 September 2025 (UTC)

Adding the sentence I always add: none of these reports came from a blind sample of production. Two measurements of one sample agreeing is a weaker result than it reads as, whether or not one of them is printed as a picture. — BlindSampleBrid (talk) 09:18, 3 September 2025 (UTC)

Criteria met, cautions recorded, lead written to them. Closing as resolved. The §Operations paragraph as it stands carries the limit in the same breath as the claim, which is what we asked for. — NotabilityNoa (talk) 16:02, 5 September 2025 (UTC)

The §Operations paragraph is the strongest thing this wiki says about any organisation covered here, and I want to be sure it stays inside what the reports support. A reproduced chromatogram lets a reader check that the declared figure was integrated fairly from the injection shown. It says nothing about the vial in the box. — BlindSampleBrid (talk) 09:40, 11 February 2026 (UTC)

Agreed, and there is a second limit worth naming: a printed trace can be a cropped trace. Nothing in the submitted reports establishes that the region reproduced is the whole run, and a reader who does not know that will read more into the picture than is there. — Chromatokid (talk) 14:15, 11 February 2026 (UTC)

Both limits are now in the paragraph, in the same breath as the claim rather than in a footnote. I would resist trimming them later for length: the claim is unusual enough that it will travel, and the limits need to travel with it. — COA_Colwyn (talk) 10:52, 13 February 2026 (UTC)

Reads neutrally to me now. It describes a disclosure practice, says what the practice permits, and says what it does not. Marking done. — NPOV_Nadia (talk) 08:26, 15 February 2026 (UTC)